Microbot Medical
MBOT | NASDAQ
$0.64
-$0.34 (-34.61%)
At close: Nov 16, 2026, 4:00 PM ET
$0.66
+$0.02 (+2.63%)
After-hours:
Nov 16, 2026, 7:58 PM ET
Microbot Medical Company Profile
Company profile explainedCompany Profile
Microbot Medical Inc. operates as a pre-clinical stage medical device company, concentrating its efforts on the research, design, and development of robotic instruments for endoluminal surgery, specifically targeting the field of minimally invasive procedures. Leveraging its proprietary micro-robotic technologies, which include ViRob, TipCAT, CardioSert, and Liberty, the company is actively developing several key products. These include a Self-Cleaning Shunt intended for the treatment of hydrocephalus and normal pressure hydrocephalus, as well as a single-use robotic system designed for various endovascular interventional applications. Additionally, Microbot Medical maintains a robust, multi-generational product pipeline. Its global intellectual property portfolio is substantial, encompassing 42 granted or allowed patents and an additional 23 patent applications currently under review. The company also benefits from a strategic collaboration agreement with Stryker Corporation, focusing on joint technology development. Established in 2010, Microbot Medical Inc. is headquartered in Hingham, Massachusetts.
Key Executives
| Name | Position |
|---|---|
| Harel Gadot | Co-Founder, President, Chief Executive Officer & Chairman |
| Rachel Vaknin | Chief Financial Officer |
| Simon Sharon | Chief Technology Officer & GM of Microbot Israel |
| Allison Rosefort | Vice President of Marketing |
| Christina Bailey | Vice President of Sales |
| Juan Diaz-Cartelle | Chief Medical Officer |
| Michael Lytle | Head of Sales Operations & Analytics |
| Naama Moav | Vice President of Human Resources |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 27, 2026 | 8-K | Current Report |
| Oct 23, 2026 | 8-K | Current Report |
| Oct 20, 2026 | 8-K | Current Report |
| Oct 06, 2026 | 8-K | Current Report |
| Sep 28, 2026 | 8-K | Current Report |
| Aug 11, 2026 | 8-K | Current Report |
| Aug 11, 2026 | 10-Q | Quarterly Report |
| Aug 07, 2026 | 8-K | Current Report |
| Jul 21, 2026 | 8-K | Current Report |
| Jul 07, 2026 | 8-K | Current Report |
Microbot Medical
| Country | United States |
| IPO Date | Mar 25, 1992 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 43 |
| CEO | Harel Gadot |
Contact Details
175 Derby Street Hingham,
Massachusetts 02043 United States
Stock Details
| Ticker Symbol | MBOT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000883975 |
| CUSIP Number | 59503A204 |
| ISIN Number | US59503A2042 |
| SIC Code | 2836 |
Add to Watchlist
Select watchlists to add or remove MBOT